Microfluidic Technologies for cfDNA Isolation and Analysis

Microfluidic Technologies for cfDNA Isolation and Analysis

Cell-free DNA (cfDNA), which promotes precision oncology, has received extensive concern because of its abilities to inform genomic mutations, tumor burden and drug resistance. The absolute quantification of cfDNA concentration has been proved as an independent prognostic biomarker of overall surviv...

Bibliografske podrobnosti
Main Authors:	Zheyun Xu, Yi Qiao, Jing Tu
Format:	Article
Jezik:	English
Izdano:	MDPI AG 2019-10-01
Serija:	Micromachines
Teme:	microfluidics loc cfdna isolation cfdna analysis
Online dostop:	https://www.mdpi.com/2072-666X/10/10/672

Podobne knjige/članki

The cfDNA in early cancer detection
od: Hussein Adil Abid, et al.
Izdano: (2024-01-01)

Deep cfDNA fragment end profiling enables cancer detection
od: Yulia V. Zhitnyuk, et al.
Izdano: (2022-01-01)

cfDNA in pancreatic neuroendocrine carcinoma management with Cushing’s syndrome
od: Laura Gerard, et al.
Izdano: (2023-01-01)

Diagnostic Value of cfDNA in Pancreatic Cancer
od: XU Yijun, et al.
Izdano: (2022-12-01)

Exploration of cfDNA landscape in NIPT and clinical utilities of cfDNA based gene expression inference in prenatal diagnostics
od: Ruo Jia, et al.
Izdano: (2025-02-01)

Fragmentomic cfDNA Patterns in Noninvasive Prenatal Testing and Beyond
od: Kavish Kohabir, et al.
Izdano: (2021-04-01)

What fraction of cellular DNA turnover becomes cfDNA?
od: Ron Sender, et al.
Izdano: (2024-02-01)

Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer
od: Zhong Y, et al.
Izdano: (2020-05-01)

Early detection of uterine corpus endometrial carcinoma utilizing plasma cfDNA fragmentomics
od: Jing Liu, et al.
Izdano: (2024-07-01)

cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps
od: Xiao-Hong Li, et al.
Izdano: (2022-12-01)

Effect of acute moderate-intensity cycling on cfDNA levels considering menstrual cycle phases
od: Akemi Sawai, et al.
Izdano: (2024-01-01)

Unlocking the secrets: the power of methylation-based cfDNA detection of tissue damage in organ systems
od: Lijing Zhang, et al.
Izdano: (2023-10-01)

Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker
od: Lucija Škara, et al.
Izdano: (2023-01-01)

Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer
od: Daniel Fernandez-Garcia, et al.
Izdano: (2019-12-01)

Liver Transplantation and dd-cfDNA: A Small Solution for a Big Problem
od: Eleni Avramidou, et al.
Izdano: (2023-02-01)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
od: Jennifer A. Fairley, et al.
Izdano: (2022-07-01)

Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort
od: Stephen R. Fairclough, et al.
Izdano: (2019-10-01)

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation
od: Evangelos Mantios, et al.
Izdano: (2023-10-01)

Quantification of mitochondrial cfDNA reveals new perspectives for early diagnosis of colorectal cancer
od: Christian Linke, et al.
Izdano: (2023-03-01)

A Fully Integrated Microfluidic Device with Immobilized Dyes for Simultaneous Detection of Cell-Free DNA and Histones from Plasma Using Dehydrated Agarose Gates
od: Shadi Shahriari, et al.
Izdano: (2024-03-01)

Beyond the Blood: CSF-Derived cfDNA for Diagnosis and Characterization of CNS Tumors
od: Abbye E. McEwen, et al.
Izdano: (2020-02-01)

Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis
od: Nicholas Kueng, et al.
Izdano: (2023-07-01)

Plasma cfDNA VILL gene methylation as a diagnostic marker for nasopharyngeal carcinoma
od: Xiao-Yan Fu, et al.
Izdano: (2025-02-01)

Isolation of cfDNA from spent culture media and its association with implantation rate and maternal immunomodulation
od: Amin Alizadegan, et al.
Izdano: (2022-07-01)

The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
od: Xiaolong Zhao, et al.
Izdano: (2021-07-01)

Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED)
od: Pin Cui, et al.
Izdano: (2024-02-01)

Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer
od: Xin Yang, et al.
Izdano: (2019-05-01)

Value of altered methylation patterns of genes RANBP3, LCP2 and GRAP2 in cfDNA in breast cancer diagnosis
od: Hu Qin, et al.
Izdano: (2024-01-01)

Detection of neuron-derived cfDNA in blood plasma: a new diagnostic approach for neurodegenerative conditions
od: Chad Pollard, et al.
Izdano: (2023-10-01)

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
od: José Manuel González de Aledo-Castillo, et al.
Izdano: (2021-07-01)

Promoter profiles in plasma CfDNA exhibits a potential utility of predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients
od: Xu Yang, et al.
Izdano: (2024-07-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
od: Stine H. Kresse, et al.
Izdano: (2023-09-01)

Cell-free DNA in medium is associated with the maturation ability of in vitro cultured oocytes
od: Yasuhisa MUNAKATA, et al.
Izdano: (2019-02-01)

Integrating cfDNA liquid biopsy and organoid-based drug screening reveals PI3K signaling as a promising therapeutic target in colorectal cancer
od: Huan Yang, et al.
Izdano: (2024-02-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
od: Daniel R. A. Cox, et al.
Izdano: (2023-06-01)

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
od: Louise Benning, et al.
Izdano: (2023-11-01)

Salivary Exosome and Cell-Free DNA for Cancer Detection
od: Kyung-A Hyun, et al.
Izdano: (2018-07-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
od: Morten Lapin, et al.
Izdano: (2018-11-01)

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer
od: Sai Ren, et al.
Izdano: (2023-10-01)

Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
od: Keerthi Ranganathan, et al.
Izdano: (2024-09-01)